Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Diseases, Metabolic × Risedronic Acid × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Other hematologic neoplasm 1 Lymphoid 1 Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteoporosis 1 Lymphoma 1 Leukemia 1 Bone Diseases, Metabolic 1

Interventions

Vitamin D 2 Zoledronic Acid 1 Risedronic Acid 1 Calcium Carbonate 1 Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed

72 enrolled 8 charts

LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡